Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [41] Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
    Romano, Marco
    Cuomo, Antonio
    Gravina, Antonietta G.
    Miranda, Agnese
    Iovene, Maria Rosaria
    Tiso, Angelo
    Sica, Mariano
    Rocco, Alba
    Salerno, Raffaele
    Marmo, Riccardo
    Federico, Alessandro
    Nardone, Gerardo
    GUT, 2010, 59 (11) : 1465 - 1470
  • [42] Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection?
    O'Morain, Colm A.
    O'Connor, J. P. Anthony
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (01): : 8 - 9
  • [43] Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children
    Yang, YJ
    Yang, JC
    Jeng, YM
    Chang, MH
    Ni, YH
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (07) : 662 - 666
  • [44] Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication
    Trifan, Anca
    Girleanu, Irina
    Cojocariu, Camelia
    Sfarti, Catalin
    Singeap, Ana Maria
    Dorobat, Carmen
    Grigore, Lucia
    Stanciu, Carol
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (42) : 7476 - 7479
  • [45] Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis
    Tong, J. L.
    Ran, Z. H.
    Shen, J.
    Xiao, S. D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (01) : 41 - 53
  • [46] Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori
    Fiorini, Giulia
    Zullo, Angelo
    Vakil, Nimish
    Saracino, Ilaria M.
    Ricci, Chiara
    Castelli, Valentina
    Gatta, Luigi
    Vaira, Dino
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (02) : 137 - 140
  • [47] Incidence of Helicobacter pylori infection and their clarithromycin-resistant strains in otitis media with effusion regarding phenotypic and genotypic studies
    Melake, Nahla A.
    Shaker, Ghada H.
    Salama, Magdy A.
    SAUDI PHARMACEUTICAL JOURNAL, 2012, 20 (04) : 345 - 353
  • [48] Meta-analysis: Is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
    Yoon, Hyuk
    Lee, Dong Ho
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Kang, Kyu Keun
    Oh, Dong Hyun
    Jang, Dong Kee
    Chung, Jun-Won
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (12) : 1801 - 1809
  • [49] Sequential Therapy Compared with Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Double-Blind, Randomized, Controlled Trial
    Albrecht, Piotr
    Kotowska, Maria
    Szajewska, Hania
    JOURNAL OF PEDIATRICS, 2011, 159 (01) : 45 - 49
  • [50] Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy
    Chang, Young Woon
    Park, Yoo Min
    Oh, Chi Hyuk
    Oh, Shin Ju
    Cho, Jun-Hyung
    Kim, Jung-Wook
    Jang, Jae-Young
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (03) : 574 - 581